APPG responds to CDF consultation APPG on Pancreatic Cancer has responded to proposed changes to the Cancer Drugs Fund The APPG on Pancreatic Cancer has responded to the National Institute for Health and Care Excellence (NICE) and NHS England’s consultation on proposals for a new Cancer Drugs Fund (CDF) operating model. Read the full consultation response: CDF NICE-NHSE […]

Further action needed to improve treatment, care and outcomes for pancreatic cancer patients New report considers what progress has been made on implementing the recommendations of the APPG’s 2013 and 2014 inquiries The APPG on Pancreatic Cancer has today published a follow-up report looking at which of the APPG’s recommendations have been implemented, where progress has […]

MINUTES OF THE APPG MEETING OF 25th JUNE, 10AM  Parliamentary Members in attendance: Nic Dakin MP (Chair); Stuart Andrew MP; Karen Lumley MP; Sheryll Murray MP; Margaret Ritchie MP; Mark Durkan MP; Nick Thomas-Symonds MP; Richard Benyon MP; Lord Aberdare; Lady Sylvia Hermon MP.

Minutes of the APPG meeting of 11th March, 8.30am, with Professor Dame Sally Powell Members in Attendance: Eric Ollerenshaw MP (Chair) Nic Dakin MP Lord Aberdare Stuart Anfrew MP Mark Durkan MP Pauline Latham MP External stakeholders present: Professor Nigel Heaton, Kings College Hospital; Dr Andrew Hart, President of the Pancreatic Society of Great Britain […]

Action needed to break the vicious circle holding back pancreatic cancer research in the UK New Inquiry highlights key reasons why research into pancreatic cancer remains critically underfunded and unpopular A parliamentary Inquiry looking at pancreatic cancer research has set out a series of compelling recommendations aimed at improving the levels of funding in the […]

Evidence was taken frrom the following witnesses: Mr Chris Carrigan- Director of the National Cancer Intelligence Network and Director of Information Services, Public Health England. Dr Andrew Millar – Pathway Director for hepato-pancreatic-biliary (HPB) cancer, London Cancer Mr Satvinder Mudan – Consultant Surgeon and Surgical Oncologist, The Royal Marsden, Chair of the Hepato-pancreatic-bilary Pathway Group […]

The APPG Inquiry heard evidence from Cancer Research UK’s Strategy Director, Nick Grant, and Jeff Evans, Professor of Translational Research at Cancer Research UK’s Beatson Institute in Glasgow. Nick Grant explained Cancer Research UK’s new Research Strategy in more detail, setting out how they would seek to double or treble funding into pancreatic cancer research […]

The APPG, Chaired by Eric Ollerenshaw MP, took evidence from a variety of witnesses about the barriers to more effective pancreatic cancer research in the UK. Professor Duncan Jodrell, of the Cancer Research UK Cambridge Institute, who is Professor of Cancer Therapeutics at the University of Cambridge. Professor Jodrell is also part of the US […]

The APPG, Chaired by Eric Ollerenshaw OBE MP, began its Inquiry into pancreatic cancer research by taking evidence from pancreatic cancer researchers and the three pancreatic cancer charities – Pancreatic Cancer Action, Pancreatic Cancer Research Fund and Pancreatic Cancer UK.